1.
Covington,
M.F.,
et al.,
The Future of Contrast-Enhanced Mammography.
AJR Am J Roentgenol,
2017: p.
1-9.
2.
Di Prete,
O.,
et al.,
Screening Digital Mammography Recall Rate: Does It Change with Digital Breast Tomosynthesis Experience? Radiology,
2017: p.
170517.
3.
James,
J.R.,
et al.,
Breast Radiation Dose With CESM Compared With 2D FFDM and 3D Tomosynthesis Mammography.
AJR Am J Roentgenol,
2017.
208(2): p.
362-372.
4.
Mamoulakis,
C.,
et al.,
Contrast-induced nephropathy: Basic concepts,
pathophysiological implications and prevention strategies.
Pharmacol Ther,
2017.
180: p.
99-112.
5.
Nyman,
U.,
et al.,
Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Acta Radiol,
2008.
49(6): p.
658-67.
6.
Khatami,
M.R.,
et al.,
A comparison of definitions of contrast-induced nephropathy in patients with normal serum creatinine.
Saudi J Kidney Dis Transpl,
2016.
27(1): p.
94-100.
7.
Mazzantini,
V.
and A.
Solini Determinanti metabolici ed ormonali della funzione renale nell’obesità patologica.
2015.